Moderna had already started a Phase 1/2 trial of its bird flu (H5N1) vaccine and reported strong early results.

Merck held talks over a potential $3 billion acquisition of MoonLake Immunotherapeutics, as it seeks to replenish its drug pipeline ...

Moderna (NASDAQ: MRNA) stock represented the ticket to an investing win. The company brought its coronavirus vaccine from ...

During his confirmation hearings, Kennedy promised that he would not interfere with established immunization schedules. His ...

US growth likely to slow to 1.6% this year, hobbled by Trump's trade wars, OECD says. U.S. economic growth will slow to 1.6% this year from 2.8% last year as President ...

The U.S. Food and Drug Administration has approved a new lower-dose vaccine for active immunization against COVID-19 caused ...

U.S. Health and Human Services Secretary Robert F. Kennedy Jr. said on Tuesday that Moderna has agreed to a true ...

Unpredictable and politically driven regulatory approaches cultivate an environment of enormous uncertainty for vaccine ...

Mount Etna has again captivated the world with a spectacular show.

Although it appears not to cause more severe illness, preliminary data demonstrate that the variant exhibits significant ...

The biotech’s mRNA vaccines were lauded by the first Trump administration but now are caught up in government changes to ...

The World Health Organization has tracked a new COVID-19 variant that has emerged across multiple region. Amid this, the Food ...